Studying genetic changes in melanoma

Have you ever wondered why some melanoma patients do better than others? How is this linked to changes in our genes? In this video, I will highlight part of my research as a PhD student at the Wellcome Sanger Institute in Cambridge, UK.   To learn more, check outRead More

MELGEN at the European Researchers’ Night 2018!

European Researchers’ Night is an annual open science initiative that occurs in September which is dedicated to bringing popular science and the work of scientists into the general public. Over the course of two days, there are several events that are organized across Europe which help to interact andRead More

15th Annual Joint GenoMEL/BioGenoMEL/MELGEN Scientific Meeting 2018

From the 20th to the 22nd March 2018 the MELGEN Consortium joined forces with the GenoMEL and BioGenoMEL consortia to hold their annual scientific meeting, this year hosted by the University Hospital Essen in Germany. In contrast to last year’s sun and high temperatures, the start of this year’sRead More

Running for a good cause

The Chariots of Fire is an annual relay race for charity held in Cambridge. It follows the famous path taken in the movie of the same name which tells the story of Harold Abrahams, a Cambridge runner, and his bid to win a gold medal in the 1924 Olympics. Fellow MELGENRead More

14th Annual Joint GenoMEL/BioGenoMEL/MELGEN Scientific Meeting 2017

From the 15th to the 17th May 2017, the MELGEN researchers, together with their group leaders, will be gathering in Camogli, Italy to attend the 14th annual scientific meeting of the GenoMEL, BioGenoMEL and MELGEN consortia. Founded in 1997, the GenoMEL consortium was formed by a number of melanomaRead More

What scientists mean by “heterogeneity” and why you should care

The term “diversity” is frequently circulated in our modern world. We are all different: we look different, have different personalities, and like different things. This is easy for us to understand and accept, yet it is only recently that this truth has been acknowledged in for example cancer drug development.Read More